Heart Disease News and Research

Latest Heart Disease News and Research

Prediction tool indicates prognosis after cardiac arrest

US researchers report the development of a prediction tool that could help determine neurologic prognosis after in-hospital cardiac arrest.

9 Jul 2012

Childbearing may reduce mortality in later life

All-cause mortality rates fall progressively among women aged 60–76 years the more children they have borne, show Australian study results.

9 Jul 2012

A little exercise per day keeps hypertension away

Researchers have found evidence that shows exercise intensity mediates the progression from prehypertension to hypertension.

9 Jul 2012

Humana acquires national chronic-care provider, SeniorBridge

Humana Inc. announced today it has completed its acquisition of SeniorBridge, a national chronic-care provider best known for providing in-home care management and caregiving services for seniors.

9 Jul 2012

Gene defect linked to cluster of systemic complications

Research teams from The University of Texas Health Science Center at Houston (UTHealth) and Paris, France have discovered a gene defect linked to a cluster of systemic complications, including life-threatening thoracic aortic disease and intracranial aneurysms. The new syndrome is similar, but distinct from known syndromes such as Marfan and Loeys-Dietz syndrome.

9 Jul 2012

Special surface coating for stents to keep them in place

If a person's windpipe is constricted, an operation in which the surgeon inserts a stent to enlarge the trachea is often the only way to relieve their respiratory distress. But this grid-like implant can slip out of position, closing off the windpipe altogether. Researchers are working on a special surface coating for the stents to keep them in place.

9 Jul 2012

Acusphere completes MAA dossier for Imagify to detect CAD

Acusphere, Inc. today announced that it had completed the Marketing Authorisation Application dossier for its lead product candidate, Imagify (Perflubutane Polymer Microspheres) for Injectable Suspension, and is now starting the process of filing the MAA dossier with the European Medicines Agency to support the regulatory review of Imagify in the European Union.

9 Jul 2012

Consumer Reports investigates hospital safety

The magazine offers its rankings of the safest and most dangerous hospitals based on six criteria.

9 Jul 2012

Spacelabs receives FDA 510(k) clearance for Blease900 Ventilator

Spacelabs Healthcare today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Blease900 Ventilator - an integral component of its BleaseFocus anesthesia system - paving the way for launch of the new BleaseFocus anesthesia system to healthcare facilities in the United States.

9 Jul 2012

Novel treatment for cancer based on protein from HIV-1 virus

Yissum, Research and Development Company of the Hebrew University of Jerusalem, introduces a novel method for treating cancer based on Vif, a protein isolated from the Human Immunodeficiency Virus (HIV-1). The method was invented by Professor Emeritus Moshe Kotler and Dr. Roni Nowarski from the Department of Immunology and Cancer Research at the Hebrew University.

9 Jul 2012

Treatment of Schizophrenia receives notice of intention to grant a European patent

BioLineRx (NASDAQ:BLRX)(TASE:BLRX), a biopharmaceutical development company, announced today that it has received from the European Patent Office a notice of intention to grant a European patent claiming the salt of BL-1020, a first-in-class orally available treatment for schizophrenia.

9 Jul 2012

ImaCor releases Zura EVO ultrasound system

ImaCor Inc., the pioneer of the world's only hemodynamic transesophageal echocardiography (hTEE) management device, today released the Zura EVO ultrasound system.

9 Jul 2012

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) filed on May 2, 2012 for XARELTO (rivaroxaban), an oral anticoagulant, seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent recurrent DVT and PE.

9 Jul 2012

FDA approves Capricor’s IND application for myocardial infarction study

Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).

9 Jul 2012

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.

9 Jul 2012

PsiOxus closes Series B round of equity financing

PsiOxus Therapeutics, Ltd. announced that it has closed a Series B round of equity financing totaling £22 million ($34 million).

9 Jul 2012

DNA from CF patients with and without chronic infections points to unsuspected mutation

Comparing the DNA from patients at the best and worst extremes of a health condition can reveal genes for resistance and susceptibly. This approach discovered rare variations in the DCTN4 gene among cystic fibrosis patients most prone to early, chronic airway infections.

9 Jul 2012

Conference highlights utility of zebrafish for human disorder studies

Zebrafish, popular as aquarium fish, now have an important place in research labs as a model organism for studying human diseases.

8 Jul 2012

Extra weight not necessarily linked with higher risk of death

An evaluation of national data by UC Davis researchers has found that extra weight is not necessarily linked with a higher risk of death.

7 Jul 2012

SAGE sponsors symposium on cardiovascular disease prevention

European experts in cardiovascular medicine will today gather at a two day symposium to address the national agenda on cardiovascular disease prevention, held at Imperial College London and sponsored by leading independent academic and professional publisher SAGE.

7 Jul 2012